תאריך: 23/11/2017 - 25/11/2017
Chairpersons: Barak Zafrir and Ofir Avizohar
Pharmacogenomic application of the Haptoglobin genotype in the prevention and treatment of Diabetic Cardiovascular Disease
Pharmacogenomic application of the Haptoglobin genotype in the prevention and treatment of Diabetic Cardiovascular DiseaseAndrew Levy
Technion Faculty of Medicine, Israel
New Diabetes Treatments with Cardiovascular Outcome Benefit: A Changing Role for the Cardiologist and Non-diabetologist
New Diabetes Treatments with Cardiovascular Outcome Benefit: A Changing Role for the Cardiologist and Non-diabetologistYoseph Rozenman
Tel Aviv University, Israel
Type 2 Diabetes: Approach to Management and Real-world Cases of Diabetics with CVD
Type 2 Diabetes: Approach to Management and Real-world Cases of Diabetics with CVDRoy Eldor
Tel-Aviv Sourasky Medical Center, Israel